Emir Muzurović

998 total citations · 1 hit paper
29 papers, 540 citations indexed

About

Emir Muzurović is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Emir Muzurović has authored 29 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Emir Muzurović's work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Emir Muzurović is often cited by papers focused on Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Emir Muzurović collaborates with scholars based in Montenegro, Slovenia and United Kingdom. Emir Muzurović's co-authors include Dimitri P. Mikhailidis, Christos S. Mantzoros, Manfredi Rizzo, Andrej Janež, Ivana Kraljević, Mirsala Solak, Anca Pantea Stoian, Michail Kokkorakis, Marlene Chakhtoura and Michael A. Hill and has published in prestigious journals such as Pharmacological Reviews, International Journal of Molecular Sciences and Metabolism.

In The Last Decade

Emir Muzurović

25 papers receiving 533 citations

Hit Papers

Non-alcoholic fatty liver disease, insulin resistance, me... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
    2021 198 citations Emir Muzurović, Dimitri P. Mikhailidis et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emir Muzurović Montenegro 12 270 232 131 126 106 29 540
Maria Elena Lunati Italy 11 332 1.2× 149 0.6× 171 1.3× 159 1.3× 101 1.0× 27 640
Song Lu China 16 255 0.9× 275 1.2× 136 1.0× 128 1.0× 105 1.0× 23 662
Xiaoming Tao China 13 162 0.6× 167 0.7× 60 0.5× 135 1.1× 55 0.5× 22 479
Dalong Zhu China 14 194 0.7× 175 0.8× 94 0.7× 169 1.3× 169 1.6× 26 545
Yoshitaka Ando Japan 18 258 1.0× 375 1.6× 83 0.6× 469 3.7× 193 1.8× 62 980
Carla Ferri Spain 14 134 0.5× 101 0.4× 110 0.8× 166 1.3× 36 0.3× 33 691
Asuka Hino Japan 9 180 0.7× 142 0.6× 71 0.5× 93 0.7× 140 1.3× 14 694
Zhijuan Ge China 13 100 0.4× 164 0.7× 89 0.7× 216 1.7× 97 0.9× 22 542
Merja Santaniemi Finland 15 209 0.8× 502 2.2× 70 0.5× 182 1.4× 314 3.0× 22 911
Eugène H. J. M. Jansen Netherlands 8 121 0.4× 142 0.6× 51 0.4× 45 0.4× 116 1.1× 8 420

Countries citing papers authored by Emir Muzurović

Since Specialization
Citations

This map shows the geographic impact of Emir Muzurović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emir Muzurović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emir Muzurović more than expected).

Fields of papers citing papers by Emir Muzurović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emir Muzurović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emir Muzurović. The network helps show where Emir Muzurović may publish in the future.

Co-authorship network of co-authors of Emir Muzurović

This figure shows the co-authorship network connecting the top 25 collaborators of Emir Muzurović. A scholar is included among the top collaborators of Emir Muzurović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emir Muzurović. Emir Muzurović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solak, Mirsala, et al.. (2025). Hypopituitarism and Cardiovascular Risk. Journal of Cardiovascular Pharmacology and Therapeutics. 30. 2244890414–2244890414.
2.
3.
Jensterle, Mojca, et al.. (2025). Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity. Diabetes Therapy. 16(6). 1207–1227. 7 indexed citations
4.
Muzurović, Emir, et al.. (2025). Incretin-based Agents and Metabolic Dysfunction-associated Steatotic Liver Disease. Current Pharmaceutical Design. 31. 1 indexed citations
5.
Muzurović, Emir, et al.. (2025). Epicardial Adipose Tissue Modulation: A New Horizon for Sodium-glucose Cotransporter 2 Inhibitors. Current Vascular Pharmacology. 23(4). 231–232.
6.
7.
Kokkorakis, Michail, Emir Muzurović, Marlene Chakhtoura, et al.. (2024). Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological Reviews. 76(3). 454–499. 36 indexed citations
8.
Katsiki, Niki, et al.. (2024). Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment. Progress in Cardiovascular Diseases. 85. 14–25. 10 indexed citations
9.
10.
Popović, Nataša, et al.. (2023). Timing Is Important—Management of Metabolic Syndrome According to the Circadian Rhythm. Biomedicines. 11(4). 1171–1171. 6 indexed citations
11.
Salmen, Teodor, Cristian Serafinceanu, Emir Muzurović, et al.. (2023). A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy—A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 24(11). 9760–9760. 12 indexed citations
12.
Giglio, Rosaria Vincenza, Emir Muzurović, Angelo Maria Patti, et al.. (2023). Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm?. Journal of Cardiovascular Pharmacology and Therapeutics. 28. 2224744871–2224744871. 3 indexed citations
13.
Muzurović, Emir, et al.. (2022). Parathyroid hormone and calcitonin response during the calcium infusion test in patients with primary hyperparathyroidism. HORMONES. 21(2). 261–270. 2 indexed citations
14.
15.
16.
Muzurović, Emir, Dimitri P. Mikhailidis, & Christos S. Mantzoros. (2021). Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 119. 154770–154770. 198 indexed citations breakdown →
17.
Muzurović, Emir & Dimitri P. Mikhailidis. (2020). Diabetes Mellitus and Noncardiac Atherosclerotic Vascular Disease—Pathogenesis and Pharmacological Treatment Options. Journal of Cardiovascular Pharmacology and Therapeutics. 26(1). 25–39. 10 indexed citations
18.
Muzurović, Emir, et al.. (2020). Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players. Current Pharmaceutical Design. 27(27). 3020–3035. 12 indexed citations
19.
Muzurović, Emir, et al.. (2020). Weight-centric pharmacological management of type 2 diabetes mellitus – An essential component of cardiovascular disease prevention. Journal of Diabetes and its Complications. 34(8). 107619–107619. 9 indexed citations
20.
Muzurović, Emir, et al.. (2018). The role of lipids in prediction of gestational diabetes mellitus. Endocrine Abstracts.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Elena Lunati Breakdown of academic impact, for papers by Song Lu Breakdown of academic impact, for papers by Xiaoming Tao Breakdown of academic impact, for papers by Dalong Zhu Breakdown of academic impact, for papers by Yoshitaka Ando Breakdown of academic impact, for papers by Carla Ferri Breakdown of academic impact, for papers by Asuka Hino Breakdown of academic impact, for papers by Zhijuan Ge Breakdown of academic impact, for papers by Merja Santaniemi Breakdown of academic impact, for papers by Eugène H. J. M. Jansen
Rankless by CCL
2026